123 related articles for article (PubMed ID: 36906972)
41. Long-term Quality of Life and Sexual Function After Neoadjuvant Chemotherapy and Radical Surgery for Locally Advanced Cervical Cancer.
Palaia I; Santangelo G; Caruso G; Perniola G; Tibaldi V; Muzii L; Benedetti Panici P; Di Donato V
J Sex Med; 2022 Apr; 19(4):613-619. PubMed ID: 35227622
[TBL] [Abstract][Full Text] [Related]
42. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
43. Combination therapy of liposomal paclitaxel and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Li Y; Wang X; Li J; Ding W
Eur J Gynaecol Oncol; 2015; 36(1):54-8. PubMed ID: 25872335
[TBL] [Abstract][Full Text] [Related]
44. Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation.
Bertelsen BI; Steine SJ; Sandvei R; Molven A; Laerum OD
Int J Cancer; 2006 Apr; 118(8):1877-83. PubMed ID: 16287065
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P
J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397
[TBL] [Abstract][Full Text] [Related]
46. A prospective trial to evaluate the clinical efficacy and safety of neoadjuvant chemotherapy with arsenic trioxide and carboplatin in locally advanced cervical cancer: a study protocol for randomized controlled clinical.
He ZY; Li HY; Yan J; Li SJ; Li DC; Liang ZZ
Trials; 2022 Jul; 23(1):556. PubMed ID: 35804452
[TBL] [Abstract][Full Text] [Related]
47. Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research.
Gadducci A; Cosio S
Anticancer Res; 2020 Sep; 40(9):4819-4828. PubMed ID: 32878770
[TBL] [Abstract][Full Text] [Related]
48. Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer.
de Azevedo CRAS; Thuler LCS; de Mello MJG; de Oliveira Lima JT; da Fonte ALF; Fontão DFS; Carneiro VCG; Chang TMC; Ferreira CG
Gynecol Oncol; 2017 Sep; 146(3):560-565. PubMed ID: 28709705
[TBL] [Abstract][Full Text] [Related]
49. Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer.
Yu XL; Wu MF; Ding L; Yang J; Bai SM
Cancer Manag Res; 2021; 13():9297-9304. PubMed ID: 35221720
[TBL] [Abstract][Full Text] [Related]
50. Neoadjuvant Chemotherapy Followed by Chemoradiation in Cervical Carcinoma: A Review.
de Azevedo CR; Thuler LC; de Mello MJ; Ferreira CG
Int J Gynecol Cancer; 2016 May; 26(4):729-36. PubMed ID: 26905327
[TBL] [Abstract][Full Text] [Related]
51. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
52. Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience.
Adorni M; Bazzurini L; Lissoni AA; Vecchione F; Negri S; Grassi T; Buda A; Landoni F
Tumori; 2022 Oct; 108(5):495-501. PubMed ID: 34289750
[TBL] [Abstract][Full Text] [Related]
53. Neoadjuvant chemotherapy with paclitaxel plus platinum for invasive cervical cancer in pregnancy: two case report and literature review.
Li J; Wang LJ; Zhang BZ; Peng YP; Lin ZQ
Arch Gynecol Obstet; 2011 Sep; 284(3):779-83. PubMed ID: 21691768
[TBL] [Abstract][Full Text] [Related]
54. Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement.
Wang Y; Wang G; Wei LH; Huang LH; Wang JL; Wang SJ; Li XP; Shen DH; Bao DM; Gao J
Chin J Cancer; 2011 Sep; 30(9):645-54. PubMed ID: 21880186
[TBL] [Abstract][Full Text] [Related]
55. Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.
Ferrandina G; Distefano MG; De Vincenzo R; Salutari V; Petrillo M; Scarciglia ML; Pietragalla A; Conte C; Scambia G
Gynecol Oncol; 2013 Mar; 128(3):518-23. PubMed ID: 23237767
[TBL] [Abstract][Full Text] [Related]
56. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
[TBL] [Abstract][Full Text] [Related]
57. Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial.
Turner N; Dent RA; O'Shaughnessy J; Kim SB; Isakoff SJ; Barrios C; Saji S; Bondarenko I; Nowecki Z; Lian Q; Reilly SJ; Hinton H; Wongchenko MJ; Kovic B; Mani A; Oliveira M
Breast Cancer Res Treat; 2022 Feb; 191(3):565-576. PubMed ID: 34860318
[TBL] [Abstract][Full Text] [Related]
58. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
59. Neoadjuvant chemotherapy with weekly paclitaxel and carboplatin followed by chemoradiation in locally advanced cervical carcinoma: a pilot study.
Singh RB; Chander S; Mohanti BK; Pathy S; Kumar S; Bhatla N; Thulkar S; Vishnubhatla S; Kumar L
Gynecol Oncol; 2013 Apr; 129(1):124-8. PubMed ID: 23353129
[TBL] [Abstract][Full Text] [Related]
60. Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study.
Vizza E; Corrado G; Zanagnolo V; Tomaselli T; Cutillo G; Mancini E; Maggioni A
Gynecol Oncol; 2014 May; 133(2):180-5. PubMed ID: 24589412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
